Morepen Laboratories Limited has secured approval from the US Food and Drug Administration (FDA) for its anti-allergy drug Fexofinadine Hydrochloride, which it expects to begin approval in the fourth quarter of 2022. The anti-allergy drug, which is sold in India under the brand names such as Allegra and others, was developed by France-based Sanofi Aventis. […]
Aimmune Therapeutics said that the first patients in the US are being treated with the recently FDA approved peanut allergy drug PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp]. The California-based biopharma company said that specialty pharmacies are shipping initial dosing kits of the new peanut allergy drug to allergists for in-office administration to their peanut-allergic patients […]
GSK Consumer Healthcare, a division of GlaxoSmithKline PLC, has introduced a new over-the-counter (OTC) allergy relief nasal spray, Flonase Sensimist Allergy Relief. This product, featuring fluticasone furoate at 27.5 mcg per spray, promises enhanced relief for millions of allergy sufferers across the United States. Breakthrough in Allergy Relief Technology Flonase Sensimist, employing the innovative MistPro […]